This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
And one of the highest areas of opportunity for human error is in the sterile compounding process. The guidelines recognize IV workflow management systems as the minimum safety standard for preparing compounded preparations and IV robotics are recommended for high volume, large batch preparations.
Dennis Wright, Senior Director, Product Marketing, Omnicell As health systems navigate escalating staff shortages and increasingly complex drug therapies, the need for a high-performing pharmacy has never been greater. Total prescription drug spend in the US was $576.9
Carmine DeNardo VP and General Manager, Specialty Pharmacy Services, Omnicell Despite the widespread adoption of electronic health records, pharmacy management systems, and other digital technologies, managing patients and medications across the continuum of care remains a significant challenge.
Randall Lipps Chairman, President, CEO, and Founder, Omnicell Today, I was excited to join thousands of registrants representing pharmacy, nursing, informatics, and healthcare leaders for the launch of Omnicell Illuminate 2020 , one of the year’s biggest digital events dedicated to technology-driven medication management.
Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Imagine if Amazon lost one out of every 10 packages. So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Or the airlines lost 10% of passenger bags.
Many often rely on 503B outsourcing pharmacies for their pre-mixed compounded sterile products. At the University of Maryland Medical Center, we reduced our need for 503B vendors by implementing an IV robotics insourcing program for compounded sterile products (CSPs). This combination represents the net savings for the hospital.
Dennis Killian, PharmD, PhD Vice President of Clinical Operations, TidalHealth Early on in my hospital pharmacy career, I had the pleasure of working with several tenured pharmacy leaders who were winding down their careers as staff pharmacists. One of these pharmacists had served as the CEO for a local hospital.
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.
Michael Korthuis Vice President of Engineering, Omnicell The changing nature of healthcare and the shift toward value-based care has led to a growing focus on better cost management while improving care. According to an ASHP poll of hospital pharmacy personnel, pharmacists spend 26 percent of their time on clinical activities.
Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Sterile compounding is also one of the costliest functions in pharmacy operations. Insourcing IV compounding services at Moses H.
Terri Albarano, MS, PharmD Director, Autonomous Pharmacy Advisory Board When patients are admitted to the hospital, they are typically focused on receiving the best care. One key area was in sterile compounding of IVs – a big risk area – in which a dosing error could have serious consequences.
The operational blind spots caused by disconnected, siloed systems compounded by the delays and errors caused by outdated manual workflows are the hallmarks of operational complexity that impedes ideal perpetual inventory management and leads to financial strains that plague pharmacies. Although $9.9 billion on drug diversion.
Juliana Linsdell, BSN, RN Omnicell Nurse Consultant For our customer, Massachusetts General Hospital – the No. 6-ranked hospital in the country by US News & World Report – getting medications from the Central Pharmacy to patient units in seven different buildings involves a lot of walking – and elevators.
Dennis Wright Senior Director, Central Pharmacy Product Marketing, Omnicell As one of the early adopters of the vision of Autonomous Pharmacy , Texas Children's Hospital in Houston saw the opportunity for connected automation, intelligent data, and technology-enabled services to drive radical change in their medication management strategy.
Joy Somogyi Senior Director of Product Marketing and Development, Omnicell With two million people suffering from opioid addiction and 115 people dying from an opioid overdose every day in the U.S., the opioid crisis is one of the major challenges healthcare is facing, specifically for pharmacies currently managing medication diversion.
Arpit Mehta Director of Pharmacy, Allegheny General Hospital Like many health systems, we at Allegheny Health Network have been challenged by the cost, compliance, and complexity of compounding sterile products (CSPs). Omnicell's IV compounding robot service offered the holistic solution we needed.
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Despite the reality that intravenous (IV) compounding is among the highest risk areas in the continuum of acute care when it comes to the potential for possible patient harm, IV systems are often the last to be impacted by advances in pharmacy automation.
Denise Cox SVP, Chief Customer Officer, North America, Omnicell Women currently hold more than 75% of all healthcare jobs in the United States, versus just 8% in the 1960s. Implications for women of color are even worse, with only 5% of C-suite positions held by minority women.
In the premier episode of Omnicell’s The Future of Pharmacy Podcast , I join Omnicell’s Jim Stevenson, Vice President of Medication System Strategy, and host Ken Perez, to discuss the opportunity of Autonomous Pharmacy to help us achieve our patient care goals.
Howard Montgomery, MS, RPh Director, Clinical Consulting, Omnicell The biggest vaccination campaign in history is now underway and scaling fast. One of the biggest challenges is visibility to, and reporting of, vaccine data as hospitals need to comply with non-standardized processes that are still evolving and vary state to state.
Mark Neuenschwander Founding Director, THRIVCoalition.org Seminal research from 1997 on IV compounding discovered that 9 percent of manually compounded sterile preparations had incorrect ingredients and/or volumes. All this means hospitals must prepare the majority of their IVs in-house and, we believe this will continue.
Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.
Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.
Ken Perez Vice President, Healthcare Policy, Omnicell Overreliance on manual processes and siloed technology in pharmacy operations are among the biggest challenges facing health systems today. The goal of this industry movement is to achieve zero-error medication management, while freeing pharmacists to practice at the top of their license.
I was first introduced to automated dispensing cabinets for removal of medications when I graduated from nursing school and began working at a hospital in South Carolina. I quickly learned how the automation cabinets provided security and safety for patient care.
Congressional Democrats' challenges are compounded by a relatively unpopular president. The Trump administration cut Medicare Part B reimbursement to 340B hospitals by close to 30 percent. If hospital advocacy groups turn to Congress to clarify the contract pharmacy law, it is no sure thing that the effort will be successful.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content